Title

Management algorithm for subclinical hypoxemia in coronavirus disease-2019 patients: Intercepting the 'Silent Killer'

Document Type

Article

Publication Title

Journal of Emergencies, Trauma and Shock

Abstract

In the early stages of COVID-19 clinical illness, the ability to oxygenate is impaired. However, the patient does not necessarily display the conventionally expected signs or symptoms of respiratory failure, including shortness of breath. Given the above, HCP's must remain vigilant and proactively look for 'red flags' described herein, such as the appearance of =3%-5% drop in SpO2 after approximately 60 s of mild activity/ambulation, SpO2/FiO2 ratio <300, SpO2 <93% on room air, and the presence of hypoxemia without tachypnea [Figure 1].[4,11,12] In summary, this expert group views AH as the proverbial "canary in the coalmine" and the first harbinger of future respiratory deterioration in COVID-19 patients.

First Page

110

Last Page

113

DOI

10.4103/JETS.JETS_72_20

Publication Date

4-1-2020

This document is currently not available here.

Share

COinS